Pre–Human Immunodeficiency Virus (HIV) α4β7hi CD4+ T Cells and HIV Risk Among Heterosexual Individuals in Africa
Open Access
- 25 December 2024
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 231 (4) , e770-e780
Abstract
Background: CD4+ T cells expressing α4β7 are optimal targets for human immunodeficiency virus (HIV) infections, with higher pre-HIV α4β7hi expression linked to increased HIV acquisition and progression in South African women. However, similar associations were not observed in men who have sex with men or people who inject drugs in the Americas, indicating need for further research. Methods: This retrospective case-control study enrolled heterosexual men and women from South Africa (HIV Vaccine Trials Network [HVTN] 503) and East Africa (Partners Preexposure Prophylaxis/Couples’ Observational Study [PP/COS]), quantifying α4β7 expression on CD4+ T cells as a predictor of subsequent HIV risk using flow cytometry analyses. Results: Associations between α4β7hi expression and HIV acquisition varied across cohorts. In HVTN 503, women had a higher risk estimate compared to men, but this was not significant. In PP/COS, α4β7hi expression was generally protective, particularly in Ugandans. Additionally, α4β7hi expression inversely correlated with peak viral load in PP/COS but not in HVTN 503; in the latter cohort, α4β7hi expression was inversely correlated with the CD4/CD8 ratio and predicted rapid CD4+ T-cell decline, similar to what was observed previously in South Africa. Conclusions: These findings suggest that α4β7hi expression on CD4+ T cells may not predict HIV acquisition and progression in all contexts, which may be due to cohort effects, modes of transmission, viral clade, or other factors.Keywords
Funding Information
- International Congress of Immunology
This publication has 40 references indexed in Scilit:
- The association of α4β7 expression with HIV acquisition and disease progression in people who inject drugs and men who have sex with men: Case control studiesEBioMedicine, 2020
- Integrin α4β7 in HIV-1 infection: A critical reviewJournal of Leukocyte Biology, 2020
- Gut-homing α4β7 CD4+ T cells: potential key players in both acute HIV infection and HIV-associated cancersCellular & Molecular Immunology, 2017
- Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral TherapyJAMA, 2016
- Recombinant adenovirus type 5 HIV gag/pol/nef vaccine in South Africa: unblinded, long-term follow-up of the phase 2b HVTN 503/Phambili studyThe Lancet Infectious Diseases, 2014
- Phenotype and susceptibility to HIV infection of CD4+ Th17 cells in the human female reproductive tractMucosal Immunology, 2014
- The origin and diversity of the HIV-1 pandemicTrends in Molecular Medicine, 2012
- Safety and efficacy of the HVTN 503/Phambili Study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b studyThe Lancet Infectious Diseases, 2011
- α4+β7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infectionMucosal Immunology, 2009
- HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cellsNature Immunology, 2008